2021-12-19 19:24
5-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1-ethylpyrimidine-2,4(1H,3H)-dione

2021-12-19 19:24
5-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1-(ethoxymethyl)pyrimidine-2,4(1H,3H)-dione

2021-12-19 19:24
1-Benzyl-pseudouridine; 2,4(1H,3H)-Pyrimidinedione, 1-(phenylmethyl)-5-β-D-ribofuranosyl-; 1-benzyl-5-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

2021-12-19 19:23
1,2,3,6,7,11b-hexahydropyrazino[2,1-a]isoquinolin-4-one; 1,2,3,6,7,11b-hexahydropyrazino[2,1-a]isoquinolin-4-one

2021-12-19 19:23
InChI=1S/C5H12O/c1-5(2,3)4-6/h6H,4H2,1-3H3

2021-12-19 19:23
InChI=1S/C9H20O2Si/c1-8(10-5)11-12(6,7)9(2,3)4/h1H2,2-7H3

2021-12-19 19:22
(1S,2R)-1-amino-2,3-dihydro-1H-inden-2-ol; (1S,2R)-1-amino-2,3-dihydro-1H-inden-2-ol

2021-12-19 19:22
DM 4 is an intermediate used to prepare semisynthetic maytansine analogs which can be conjugated with antibodies for the targeted treatment of cancer.

2021-12-19 19:22
DM3 is a cytotoxic agent. It is used as the cytotoxic component in antibody-drug conjugates.